These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7384636)

  • 1. The influence of heparin administration on the plasma protein binding and disposition of propranolol.
    Silber B; Lo M; Riegelman S
    Res Commun Chem Pathol Pharmacol; 1980 Mar; 27(3):419-29. PubMed ID: 7384636
    [No Abstract]   [Full Text] [Related]  

  • 2. The production of free fatty acids in post-heparin plasma during equilibrium dialysis.
    Hamilton SF; Waller ES; Yakatan GJ; Ludden TM
    Res Commun Chem Pathol Pharmacol; 1982 Mar; 35(3):519-22. PubMed ID: 7079577
    [No Abstract]   [Full Text] [Related]  

  • 3. The disposition of propranolol. 3. Decreased half-life and volume of distribution as a result of plasma binding in man, monkey, dog and rat.
    Evans GH; Nies AS; Shand DG
    J Pharmacol Exp Ther; 1973 Jul; 186(1):114-22. PubMed ID: 4198771
    [No Abstract]   [Full Text] [Related]  

  • 4. Interactions of phenobarbital with propranolol in the dog. 1. Plasma protein binding.
    Bai SA; Abramson FP
    J Pharmacol Exp Ther; 1982 Sep; 222(3):589-94. PubMed ID: 7108766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arterial and venous blood sampling in pharmacokinetic studies: propranolol in rabbits and dogs.
    Lam G; Chiou WL
    Res Commun Chem Pathol Pharmacol; 1981 Jul; 33(1):33-48. PubMed ID: 7268207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A model to describe myocardial drug disposition in the dog.
    Kates RE; Jaillon P
    J Pharmacol Exp Ther; 1980 Jul; 214(1):31-6. PubMed ID: 7391969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of heparin on plasma triglycerides (TG) and non-esterified fatty acids (NEFA).
    Szostak WB; Wojnar S; Ruzyllo E; Romaniuk-Michalska E
    Pol Med Sci Hist Bull; 1968 Apr; 11(2):54-7. PubMed ID: 5652742
    [No Abstract]   [Full Text] [Related]  

  • 8. The influence of intravenous injection of heparin and nicotinic acid on (GG) plasma glyceride-glycerol and free fatty acids (FFA) level.
    Ruzyllo E; Szostak WB; Olszak W
    Pol Med Sci Hist Bull; 1968 Apr; 11(2):52-3. PubMed ID: 5649940
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of heparin on serum binding of propranolol in the acute phase of myocardial infarction.
    Sager G; Hansteen V; Aakesson I; Jacobsen S
    Br J Clin Pharmacol; 1981 Nov; 12(5):613-20. PubMed ID: 7332725
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical pharmacokinetics of propranolol.
    Routledge PA; Shand DG
    Clin Pharmacokinet; 1979; 4(2):73-90. PubMed ID: 378502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of intravenous noradrenaline infusion on plasma noradrenaline level, its urinary excretion and plasma free fatty acid concentration in dogs.
    Brzezińska Z; Nazar K; Kowalski W
    Acta Physiol Pol; 1973; 24(2):347-50. PubMed ID: 4711434
    [No Abstract]   [Full Text] [Related]  

  • 12. [Influnce of a single administration of dihydroergotamine on plasma nonesterified fatty acids in man].
    Charbonnier A; Cachin M; Bernard G
    Therapie; 1969; 24(3):399-417. PubMed ID: 5399536
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug absorption and metabolism studies by use of portal vein infusion in the rat. II. Influence of dose and infusion rate on the bioavailability of propranolol.
    Suzuki T; Isozaki S; Ishida T; Saito Y; Nakagawa F
    Chem Pharm Bull (Tokyo); 1974 Jul; 22(7):1639-45. PubMed ID: 4434590
    [No Abstract]   [Full Text] [Related]  

  • 14. Change of pharmacokinetic parameters of 131I-hippuran caused by heparin.
    Jovanović V; Maksin T; Bzenić J; Terzić N
    Nuklearmedizin; 1985 Apr; 24(2):90-2. PubMed ID: 4022787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [On the problem of the effect of heparin and albumin on bilirubin binding in exchange transfusion].
    Gostomzyk JG
    Z Kinderheilkd; 1967; 101(2):136-42. PubMed ID: 5595476
    [No Abstract]   [Full Text] [Related]  

  • 16. [Variations of plasma levels of free fatty acids after intravenous administration of heparin, in normal patients].
    Giannini SD; Diament J; Luthold W; de Paula e Silva P
    Rev Hosp Clin Fac Med Sao Paulo; 1970; 25(5):317-20. PubMed ID: 5477091
    [No Abstract]   [Full Text] [Related]  

  • 17. Stereoselective binding of the (-)-enantiomer of propranolol to plasma and extravascular binding sites in the dog.
    Bai SA; Walle UK; Wilson MJ; Walle T
    Drug Metab Dispos; 1983; 11(4):394-5. PubMed ID: 6137350
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of anticoagulants and autonomic drugs on plasma free fatty acids and glucose.
    Papacostas CA; Weiss LM; Soloff LA
    Arch Int Pharmacodyn Ther; 1970 Sep; 187(1):46-51. PubMed ID: 5480141
    [No Abstract]   [Full Text] [Related]  

  • 19. Stereoselective clearance and distribution of intravenous propranolol.
    Olanoff LS; Walle T; Walle UK; Cowart TD; Gaffney TE
    Clin Pharmacol Ther; 1984 Jun; 35(6):755-61. PubMed ID: 6734027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of food on the intravenous and oral dose kinetics of propranolol in the dog.
    Bai SA; Walle UK; Walle T
    J Pharmacokinet Biopharm; 1985 Jun; 13(3):229-41. PubMed ID: 4087163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.